Concepedia

2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis

Masayoshi Harigai, Kenji Nagasaka, Koichi Amano, Masashi Bando, Hiroaki Dobashi, Tamihiro Kawakami, Kan Kishibe, Yohko Murakawa, Joichi Usui, Takashi Wada,

Modern Rheumatology · 2018 · 69 citations · 32 references

DOI

Abstract

The revised CPG has demonstrated evidence-based treatment recommendations for AAV.

References

32

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. Charles Jennette, Ronald J. Falk, P. A. Bacon et al. · Arthritis & Rheumatism · 2012 · 6.4K citations · Full text

, , +19

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

David Jayne, Niels Rasmussen, K. Andrássy et al. · New England Journal of Medicine · 2003 · 1.4K citations

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Max Yates, Richard A. Watts, Ingeborg M. Bajema et al. · Annals of the Rheumatic Diseases · 2016 · 1.2K citations · Full text